Topiramate Tablet, Film Coated
Product Images NDC 51655-429

4 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 51655-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 01)

Structured Product Formula For Topiramate (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 01)
Chemical structure diagram of topiramate showing its molecular framework with functional groups, including methyl groups, sulfonamide, and cyclic structures.*
FDA Label Image

Structured Product Formula For Topiramate (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 02)

Structured Product Formula For Topiramate (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 02)
A Kaplan-Meier curve chart showing cumulative rates for time to first seizure over 500 days. It compares two dosage groups of topiramate: 50 mg/day (solid line) and 400 mg/day (dotted line). The vertical axis represents cumulative rates for time to first seizure, and the horizontal axis represents time in days. A p-value of 0.0002 is shown on the chart.*
FDA Label Image

Topiramate Tablets Usp (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 03)

Topiramate Tablets Usp (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 03)
A bar chart depicting the change from baseline to double-blind phase in average monthly migraine period rate (+SE) across different doses of topiramate (50 mg/day, 100 mg/day, 200 mg/day) compared to placebo. Data from two studies (Study 11 and Study 12) are shown, with sample sizes for each group labeled. Statistically significant reductions at higher doses are indicated by asterisks (* p<0.010, ** p<0.001).*
FDA Label Image

Label (51655 429 52 Rev C 01 23 Nhc)

Label (51655 429 52   Rev C 01 23 Nhc)
Topiramate Tablets USP 25 mg film-coated tablets, supplied in a package of 30 tablets by Northwind Health Company, LLC. Label includes storage instructions, dosage temperature range, and notes that the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.